- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Breakthrough pain
- Meeting Date: July 2017
- Public Summary Document (PSD) July 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2017 PBAC Meeting - Word
Fentanyl – July 2017
Fentanyl: Tablet (sublingual) 100 micrograms (as citrate) Tablet (sublingual) 200 micrograms (as citrate); Abstral®
Last updated
27 October 2017